Scarica l'app Stockscreener
3.80
1.74%
-0.0212
Precedente Chiudi:
$3.7788
Aprire:
$3.83
Volume 24 ore:
1,121
Relative Volume:
0.01
Capitalizzazione di mercato:
$15.99M
Reddito:
-
Utile/perdita netta:
$-37.75M
Rapporto P/E:
-1.1692
EPS:
-3.25
Flusso di cassa netto:
$-30.91M
1 W Prestazione:
+3.43%
1M Prestazione:
+11.17%
6M Prestazione:
+809.88%
1 anno Prestazione:
+173.03%
Intervallo 1D:
$3.77
$3.83
Intervallo di 1 settimana:
$3.3001
$3.83
Portata 52W:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Nome
Cellectar Biosciences Inc
Settore
Industria
Telefono
(608) 441-8120
Indirizzo
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Confronta CLRB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
3.77 | 16.11M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.17 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
732.93 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
466.03 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
913.19 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.56 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Ripresa | Ladenburg Thalmann | Buy |
| 2020-07-01 | Iniziato | Oppenheimer | Outperform |
| 2020-01-21 | Ripresa | ROTH Capital | Buy |
| 2019-09-13 | Iniziato | ROTH Capital | Buy |
| 2016-12-21 | Iniziato | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie
Will Cellectar Biosciences Inc. (NV4) stock deliver compounding returnsWeekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
Will Cellectar Biosciences Inc. (NV4) stock maintain strong growthJuly 2025 Price Swings & Verified Trade Idea Suggestions - Newser
Is Cellectar Biosciences Inc. (NV4) stock supported by strong fundamentalsPrice Action & High Accuracy Trade Alerts - Newser
How reliable is Cellectar Biosciences Inc. (NV4) stock dividend growthDip Buying & Stock Portfolio Risk Management - Newser
Why retail investors pile into Cellectar Biosciences Inc. stockGap Down & Advanced Swing Trade Entry Alerts - Newser
Critical Analysis: Cellectar Biosciences (NASDAQ:CLRB) & Agilent Technologies (NYSE:A) - Defense World
How strong is Cellectar Biosciences Inc. (NV4) stock earnings growthEarnings Overview Summary & Weekly Top Stock Performers List - Newser
Can Cellectar Biosciences Inc. (NV4) stock retain market dominanceTrade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
Is Cellectar Biosciences Inc. stock attractive for ETFs2025 Major Catalysts & Verified High Yield Trade Plans - Newser
Cellectar Biosciences (CLRB) Stock Analysis Report | Financials & Insights - Benzinga
Is Cellectar Biosciences Inc. stock dividend yield sustainableQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - BỘ NỘI VỤ
What drives Cellectar Biosciences Inc stock priceResistance Zone Identification & Affordable Stock Picks - earlytimes.in
Will Cellectar Biosciences Inc. stock benefit from sector rotationJuly 2025 Volume & Long Hold Capital Preservation Tips - BỘ NỘI VỤ
Cellectar Biosciences Reports Q3 2025 Financial Progress - MSN
Is Cellectar Biosciences Inc. stock near bottom after decline2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com
CLRB warrants resale, going concern warning and WM drug milestones - Stock Titan
Is Cellectar Biosciences Inc. (NV4) stock a top dividend aristocrat candidate2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
Why Cellectar Biosciences Inc. stock could outperform in 2025Portfolio Value Report & Accurate Buy Signal Notifications - newser.com
Cellectar signals 2027 global launch for iopofosine as regulatory momentum accelerates - MSN
Using R and stats models for Cellectar Biosciences Inc. forecastingTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
How Cellectar Biosciences Inc. stock performs in stagflationEarnings Risk Summary & Weekly Top Gainers Alerts - newser.com
Is Cellectar Biosciences Inc. (NV4) stock supported by free cash flowJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Will Cellectar Biosciences Inc. stock outperform tech sector in 2025Rate Cut & Weekly Chart Analysis and Trade Guides - newser.com
Will Cellectar Biosciences Inc. bounce back from current supportJuly 2025 Drop Watch & Capital Protection Trading Alerts - newser.com
Is Cellectar Biosciences Inc. stock a top pick in earnings seasonEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com
How geopolitical tensions affect Cellectar Biosciences Inc. stock - newser.com
Can Cellectar Biosciences Inc. stock hit record highs againWeekly Trade Review & Capital Efficient Trading Techniques - newser.com
How hedge fund analytics apply to Cellectar Biosciences Inc. stockPortfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Is Cellectar Biosciences Inc. stock positioned for long term growthJuly 2025 Summary & Proven Capital Preservation Methods - newser.com
What valuation ratios show for Cellectar Biosciences Inc. (NV4) stockPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Will Cellectar Biosciences Inc. (NV4) stock beat growth indexes2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Using RSI to spot recovery in Cellectar Biosciences Inc.July 2025 Action & Target Return Focused Picks - newser.com
Can Cellectar Biosciences Inc. hit a new high this monthInsider Selling & High Yield Stock Recommendations - newser.com
Is now a turning point for Cellectar Biosciences Inc.Trade Exit Summary & Weekly Breakout Watchlists - newser.com
Using data filters to optimize entry into Cellectar Biosciences Inc.Weekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
Is Cellectar Biosciences Inc. stock a bargain at current levelsWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cellectar Biosciences Inc Azioni (CLRB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
0.00%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):